GGrantIndex
← Leaderboards

Theodore R Holman

University Of California Santa Cruz

$8,552,369
Attributed
$9,925,595
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1M · FY200522
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$10,294,056 · 9

By mechanism

R01$8,881,137 · 4
S10$736,922 · 2
R21$444,875 · 1
R29$206,122 · 1
R03$25,000 · 1

Top collaborators

Others in their field

Top investigators on “Lipoxygenase

Research focus

LipoxygenaseLipoxygenase InhibitorsCellsIsoenzymesAlzheimer&AposHigh Throughput ScreeningInhibitor/AntagonistStrokeArachidonate 15-LipoxygenasePropertyDockingHuman DiseaseUnited States National Institutes Of HealthAffectTherapeutic TargetIn VivoProgramsIn VitroLearningBiochemicalCollaborationsActive SitesExcretory FunctionDrug Development

Grant awards (30)

Discovery of 12/15-lipoxygenase therapeutics for Alzheimer's disease$534,417
R01 · FY2022 · AG · contact PI
Discovery of 12/15-lipoxygenase therapeutics for Alzheimer's disease$540,683
R01 · FY2021 · AG · contact PI
Discovery of 12/15-lipoxygenase therapeutics for Alzheimer's disease$546,768
R01 · FY2020 · AG · contact PI
Discovery of 12/15-lipoxygenase therapeutics for Alzheimer's disease$552,677
R01 · FY2019 · AG · contact PI
Discovery of 12/15-Lipoxygenase Inhibitors for Alzheimer's Disease$195,875
R21 · FY2019 · AG · contact PI
Discovery of 12/15-lipoxygenase therapeutics for Alzheimer's disease$571,908
R01 · FY2018 · AG · contact PI
Discovery of 12/15-Lipoxygenase Inhibitors for Alzheimer's Disease$249,000
R21 · FY2018 · AG · contact PI
Discovery of Potent 12-Lipoxygenase Inhibitors of Platelet Activation$459,406
R01 · FY2016 · AG · contact PI
Development of Potent/Selective Lipoxygenase Therapeutics Against Stroke Injury$524,925
R01 · FY2015 · NS · contact PI
Discovery of Potent 12-Lipoxygenase Inhibitors of Platelet Activation$450,825
R01 · FY2015 · AG · contact PI
Development of Potent/Selective Lipoxygenase Therapeutics Against Stroke Injury$518,018
R01 · FY2014 · NS · contact PI
Discovery of Potent 12-Lipoxygenase Inhibitors of Platelet Activation$496,455
R01 · FY2014 · AG · contact PI
Development of Potent/Selective Lipoxygenase Therapeutics Against Stroke Injury$560,837
R01 · FY2013 · NS · contact PI
Functional and inhibitory studies of human lipoxygenase$47,582
R01 · FY2012 · GM · contact PI
Functional and inhibitory studies of human lipoxygenase$291,672
R01 · FY2011 · GM · contact PI
Functional and inhibitory studies of human lipoxygenase$20,954
R01 · FY2011 · GM · contact PI
Functional and inhibitory studies of human lipoxygenase$340,574
R01 · FY2010 · GM · contact PI
Functional and inhibitory studies of human lipoxygenase$569,530
R01 · FY2009 · GM · contact PI
Functional and inhibitory studies of human lipoxygenase$299,458
R01 · FY2009 · GM · contact PI
Functional and inhibitory studies of human lipoxygenase$15,148
R01 · FY2009 · GM · contact PI
Functional and inhibitory studies of human lipoxygenase$310,049
R01 · FY2008 · GM · contact PI
High Throughput and Virtual Screening for Human 12-LO, 15-LO-1, and 15-LO-2 Inhib$25,000
R03 · FY2007 · MH · contact PI
THERMO ELECTRON LTQ-FT MASS SPECTROMETER$368,461
S10 · FY2006 · RR · contact PI
NCRR: UCSC Acquisition of a Thermo Electron LTQ-Mass Spectrometer$368,461
S10 · FY2006 · RR · contact PI
Functional and Inhibitory Studies of Human Lipoxygenase$281,238
R01 · FY2005 · GM
Functional and Inhibitory Studies of Human Lipoxygenase$298,000
R01 · FY2004 · GM
Functional and Inhibitory Studies of Human Lipoxygenase$298,000
R01 · FY2003 · GM
Functional and Inhibitory Studies of Human Lipoxygenase$352,013
R01 · FY2002 · GM
FUNCTIONAL STUDIES OF HUMAN AND SOYBEAN LIPOXYGENASE$104,632
R29 · FY2001 · GM
FUNCTIONAL STUDIES OF HUMAN AND SOYBEAN LIPOXYGENASE$101,490
R29 · FY2000 · GM